NanoXplore Inc.
GRA.TO News Today: Stay Updated with the Latest NanoXplore Inc. News in Real Time
Find GRA.TO news now at Meyka AI. Stay informed with the latest NanoXplore Inc. stocks updates, including price news, market analysis, and expert insights.
Craig-Hallum Maintains Buy on Citi Trends, Inc. (CTRN) March 2026 PT $67
Craig-Hallum maintained Buy on Citi Trends; CTRN analyst rating kept Buy with $67 price target
Craig-Hallum Maintains Hold on Oklo Inc. (OKLO) March 2026, PT $71
Craig-Hallum maintained Hold on Oklo Inc. on March 18, 2026, cutting the PT to $71 — OKLO analyst rating explained
Craig-Hallum Maintains Buy on Xtant Medical Holdings, Inc. (XTNT) March 2026
XTNT analyst rating update: Craig-Hallum maintains Buy and lowers PT; implications for investors and valuation
SMMT Upgraded to Buy by Citigroup on April 08, 2026
Citigroup initiates coverage of Summit Therapeutics (SMMT) with Buy rating, citing scarcity value in competitive drug development landscape.
GNRSU stock The Greenrose Holding Co. (PNK) at $0.000001 on 09 Apr 2026: outlook
GNRSU stock falls to $0.000001 on 09 Apr 2026; Meyka AI grade, valuation and short-term outlook for United States PNK listing
BMO Maintains BlackLine (BL) Market Perform March 2026
BMO keeps BlackLine at Market Perform and cuts PT to $44. Read the BL analyst rating and implications
SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026
Citigroup initiates Buy coverage on Summit Therapeutics (SMMT) with initial analyst rating, citing scarcity value in competitive drug market.
SMMT Analyst Rating: Citigroup Initiates Buy Coverage April 2026
Citigroup initiates Buy coverage on Summit Therapeutics (SMMT) with initial analyst rating, citing scarcity value in competitive drug market.
Craig-Hallum Maintains Buy on comScore (SCOR) March 18, 2026
Craig-Hallum maintains Buy on comScore; latest SCOR analyst rating and implications for investors